Insider Dolan at Maravai (NASDAQ: MRVI) has 28,934 shares withheld for taxes

Rhea-AI Filing Summary

Maravai Lifesciences Holdings, Inc. Executive Vice President & General Manager, Cygnus Technologies, Christine Dolan reported an automatic share withholding related to equity compensation. On 01/15/2026, 28,934 shares of Class A common stock were withheld at $3.69 per share to cover tax obligations arising from the vesting of restricted stock unit awards held by her. After this tax withholding event, she beneficially owned 448,973 shares of Class A common stock directly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dolan Christine

(Last) (First) (Middle)

C/O MARAVAI LIFESCIENCES HOLDINGS, INC.

10770 WATERIDGE CIRCLE, SUITE 200

(Street)

SAN DIEGO CA 92121

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MARAVAI LIFESCIENCES HOLDINGS, INC. [ MRVI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

3. Date of Earliest Transaction (Month/Day/Year)
01/15/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	01/15/2026		F		28,934(1)	D	$3.69	448,973	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock unit awards held by the reporting person.

Remarks:

Executive Vice President & General Manager, Cygnus Technologies

	/s/ Kurt Oreshack, by power of attorney for Christine Dolan	01/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Christine Dolan report for MRVI?

Christine Dolan reported an automatic withholding of 28,934 shares of Maravai Lifesciences Class A common stock on 01/15/2026 to cover taxes on vested restricted stock units.

Was the MRVI insider transaction an open-market sale?

No. The filing states the 28,934 shares represent shares withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock unit awards, not a discretionary open-market sale.

At what price were the withheld MRVI shares valued in the Form 4?

The 28,934 withheld shares of Maravai Lifesciences Class A common stock were valued at $3.69 per share for tax withholding purposes.

How many MRVI shares does Christine Dolan hold after this transaction?

Following the reported tax withholding transaction, Christine Dolan beneficially owned 448,973 shares of Maravai Lifesciences Class A common stock directly.

What is Christine Dolan’s role at Maravai Lifesciences (MRVI)?

The remarks section identifies Christine Dolan as Executive Vice President & General Manager, Cygnus Technologies at Maravai Lifesciences Holdings, Inc.

What does transaction code "F" mean in the MRVI Form 4?

Transaction code "F" in the Form 4 indicates shares were withheld to pay taxes in connection with the vesting of an equity award, in this case restricted stock units.